Clinical Trials
2 trialsNCT05394285 2026-04-06
A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
Henan Cancer Hospital
Phase 2 Completed
NCT03976882 2025-05-16
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Completed